Active	Status	Sponsor type	Region	Phase	Filter
7 Active 3 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhou, Xiaoyong
NCT06109818: Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis	Recruiting	2	129	RoW	ICP-488 Tablets, ICP-488 Placebo	Beijing InnoCare Pharma Tech Co., Ltd.	Moderate to Severe Plaque Psoriasis	10/24	11/24
NCT06077331: A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis	Recruiting	2	120	RoW	HS-10374 tablets 1mg, HS-10374 tablets 5mg, HS-10374-matched placebo tablets	Hansoh BioMedical R&D Company	Psoriasis	07/24	08/24
TQH3906-II-01, NCT06542614: Treatment of Moderate to Severe Plaque Psoriasis	Recruiting	2	120	RoW	TQH3906 capsules, Placebo of TQH3906 capsules	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	Plaque Psoriasis	01/25	09/25